Fig. 1.

RET+ patient–derived cell lines. (A) Schematic describing RET rearrangements in cell lines derived from patients at University of Colorado Thoracic Oncology. (B) Table describing relevant patient characteristics, cell line growth behavior, and co-alterations detected in clinical sequencing assays. K23;R12 indicates KIF5B exon 23; RET exon 12. K15;R12 indicates KIF5B exon 15; RET exon 12. E19;R12 indicates EML4 exon 19; RET exon 12, C1;R12 indicates CCDC6 exon 1; RET exon 12. Adenomatous polyposis coli (APC), tryptophan-aspartic acid repeats (WD)